Tacrolimus-Induced Cardiomyopathy in a Kidney Transplant Recipient: A Reversible Cause of Left Ventricular Hypertrophy
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.20268gnfmbht ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Abinay Siva kumar Reddy Vanteru und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vanteru, A. S. K. R., Nemalidinne, K. V., Mahmoud, S. A. T., Alzghoul, H. M., & Khan, N. (2026). Tacrolimus-Induced Cardiomyopathy in a Kidney Transplant Recipient: A Reversible Cause of Left Ventricular Hypertrophy. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.20268gnfmbht
Vancouver
Vanteru ASKR, Nemalidinne KV, Mahmoud SAT, Alzghoul HM, Khan N. Tacrolimus-Induced Cardiomyopathy in a Kidney Transplant Recipient: A Reversible Cause of Left Ventricular Hypertrophy. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.20268gnfmbht
BibTeX
@article{Vanteru2026,
author = {Vanteru, Abinay Siva kumar Reddy and Nemalidinne, Krishna Vani and Mahmoud, Saad Abdulrahim Talal and Alzghoul, Husam Mohammad and Khan, Nasir},
title = {Tacrolimus-Induced Cardiomyopathy in a Kidney Transplant Recipient: A Reversible Cause of Left Ventricular Hypertrophy},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.20268gnfmbht}
}
EUVIMED